Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Molecular glues: Unlocking new targets in cancer

The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska Institutet and the University of Verona argue that the rest of these E3 ligases are where the next generation of cancer drugs will be found.

Molecular glues: Unlocking new targets in cancer

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Friday 20 November →